A61K 33/10
Carbonates
Official title: Carbonates; Bicarbonates
A61K33/10 (Carbonates) appears on 517 US grants and 731 published applications in this corpus.
Search patents in A61K- Granted patents
- 517
- Published applications
- 731
- Assignees
- 415
- Inventors
- 1,367
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 7 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 3 | 0 |
| 1994 | 9 | 0 |
| 1995 | 8 | 0 |
| 1996 | 11 | 0 |
| 1997 | 17 | 0 |
| 1998 | 18 | 0 |
| 1999 | 12 | 0 |
| 2000 | 17 | 0 |
| 2001 | 10 | 5 |
| 2002 | 11 | 12 |
| 2003 | 10 | 19 |
| 2004 | 9 | 20 |
| 2005 | 8 | 18 |
| 2006 | 4 | 8 |
| 2007 | 3 | 22 |
| 2008 | 3 | 22 |
| 2009 | 1 | 20 |
| 2010 | 10 | 33 |
| 2011 | 5 | 21 |
| 2012 | 11 | 38 |
| 2013 | 13 | 21 |
| 2014 | 40 | 42 |
| 2015 | 23 | 34 |
| 2016 | 23 | 48 |
| 2017 | 25 | 48 |
| 2018 | 23 | 28 |
| 2019 | 19 | 37 |
| 2020 | 24 | 32 |
| 2021 | 23 | 41 |
| 2022 | 19 | 42 |
| 2023 | 14 | 35 |
| 2024 | 18 | 35 |
| 2025 | 11 | 20 |
| 2026 | 14 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Encapsulated amorphous calcium carbonate compositions25 Aug 2026US 12,714,726 B2Amorphical Ltd.
- Essentially sodium-free effervescent solid pharmaceutical compositions28 Jul 2026US 12,691,142 B2Intas Pharmaceuticals Ltd.
- Methods and compositions for treating mucosal tissue disorders21 Jul 2026US 12,685,755 B2The University of North Carolina at Chapel Hill
- Benzimidazolone-based cinnamamide derivative as TRPV1 antagonist and pharmaceutical composition for treatment or prevention of pain containing same as active ingredient16 Jun 2026US 12,653,814 B2Jmackem Co., Ltd
- Lithium salt extended-release formulations; methods of making; and methods of use thereof19 May 2026US 12,629,339 B2Almatica Pharma LLC
- Amorphous calcium carbonate for prevention and treatment of myocardial ischemia8 Oct 2026US 2026/0306533 A1Amorphical Ltd.
- Solid forms for tissue repair1 Oct 2026US 2026/0294634 A1Cartiheal (2009) Ltd.
- Compositions and compounds including lithium orotate1 Oct 2026US 2026/0294962 A1Atlantis Software Company
- Novel alginate and cellulose derivative based composition of the liquid anti-reflux formulation24 Sep 2026US 2026/0283945 A1Danisco India Pvt. Ltd.
- Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions20 Aug 2026US 2026/0240902 A1Amorphical Ltd.
Most cited
By later US patents
- Modulated release from biocompatible polymers263US 5,656,297 AAlkermes Controlled Therapeutics, Inc. · 1997
- Plasma expander and blood substitute143US 5,571,801 ABioTime, Inc. · 1996
- Use of a porous calcium carbonate based material as support of a growth factor in the preparation of a bioabsorbable implant121US 5,711,957 AInoteb · 1998
- Electrolyte solutions and in vivo use thereof108US 4,663,166 A1987
- Prevention and treatment of retinal ischemia and edema95US 6,524,581 B1Children's Medical Center Corporation · 2003